The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma.

Zengliang Wang Yirizhati Aili Yongxin Wang Nuersimanguli Maimaitiming Hu Qin Wenyu Ji Guofeng Fan Bo Li

Published in: Oxidative medicine and cellular longevity (2022)

Our data suggest that RPL4P4 can function as an independent prognostic predictor of glioma. It also shows that RPL4P4 expression correlates with immune cell infiltration and that targeting RPL4P4 may be a new strategy for the treatment of glioma patients.

Keyphrases

chronic kidney disease
end stage renal disease
poor prognosis
ejection fraction
electronic health record
cancer therapy
newly diagnosed
machine learning
drug delivery
big data
prognostic factors
peritoneal dialysis
patient reported outcomes